Difficulties of introducing the National Service Framework for heart failure into general practice in the UK

被引:13
作者
Sparrow, N
Adlam, D
Cowley, A
Hampton, JR
机构
[1] Newthorpe Med Pract, Nottingham NG16 3HB, England
[2] Queens Med Ctr, Dept Cardiovasc Med, Nottingham NG7 2UH, England
关键词
loop diuretics; heart failure; general practice; ACE inhibitors;
D O I
10.1016/S1388-9842(03)00047-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The National Service Framework (NSF) sets standards for the management of heart failure in the UK. Loop diuretics are commonly first prescribed in primary care. Some patients taking these drugs have heart failure and may benefit from other treatments including ACE inhibitors. Accurate diagnosis in primary care is essential for the aims of the NSF to be realised. Aims: To investigate loop diuretic prescribing in general practice, to analyse recorded clinical features, patient investigations and ACE inhibitor use in this population. Method: One thousand three hundred and one patients taking loop diuretics were identified from prescription records of seven general practices. Demographic details, clinical features, investigations and drug treatments were extracted from patient records. Results: The prevalence of loop diuretic prescribing increased with age. Twenty percent of patients were attributed a diagnosis of heart failure but relevant clinical features were recorded in less than 50% of patient records. Open access echocardiography was used in 8.9% of patients. ACE inhibitors were prescribed in 39.8% of patients considered to have heart failure. 18.2% of these were taking the recommended target dose. Conclusion: Loop diuretics are prescribed commonly, particularly in the elderly. There is no clear pattern of documented clinical features that leads to prescription of these drugs. Open access echocardiography is rarely used to aid diagnosis. ACE inhibitors are under-prescribed and under-dosed in patients diagnosed with heart failure in this study population. (C) 2003 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 20 条
[1]   Secondary prevention in 24,431 patients with coronary heart disease: survey in primary care [J].
Brady, AJB ;
Oliver, MA ;
Pittard, JB .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7300) :1463-1463
[2]   USE OF MEDICATIONS BY PERSONS 65 AND OVER - DATA FROM THE ESTABLISHED POPULATIONS FOR EPIDEMIOLOGIC STUDIES OF THE ELDERLY [J].
CHRISCHILLES, EA ;
FOLEY, DJ ;
WALLACE, RB ;
LEMKE, JH ;
SEMLA, TP ;
HANLON, JT ;
GLYNN, RJ ;
OSTFELD, AM ;
GURALNIK, JM .
JOURNALS OF GERONTOLOGY, 1992, 47 (05) :M137-M144
[3]  
Clarke KW, 1995, J PUBLIC HEALTH MED, V17, P459
[4]   Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey [J].
Cleland, JGF ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Eastaugh, J ;
Follath, F ;
Freemantle, N ;
Gavazzi, A ;
van Gilst, WH ;
Hobbs, FDR ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
Swedberg, K ;
Widimsky, J .
LANCET, 2002, 360 (9346) :1631-1639
[5]  
Department of Health, 2000, NAT SERV FRAM COR HE
[6]  
Hjalmarson Å, 1999, LANCET, V353, P2001
[7]  
Hobbs FDR, 2000, BRIT J GEN PRACT, V50, P735
[8]  
Lechat P, 1999, LANCET, V353, P9
[9]   Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure [J].
Packer, M ;
Poole-Wilson, PA ;
Armstrong, PW ;
Cleland, JGF ;
Horowitz, JD ;
Massie, BM ;
Rydén, L ;
Thygesen, K ;
Uretsky, BF .
CIRCULATION, 1999, 100 (23) :2312-2318
[10]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717